How does immunotherapy help in preventing type 1 diabetes?

Question

Hi doctor,

My younger brother is 15 years old, and I am scared he might be at risk for type 1 diabetes. I have been reading about immunotherapy and how it can help with T1D prevention in people who are considered high-risk. Are there any new advancements in this area that can help preserve beta cells and prevent the autoimmune attack that leads to type 1 diabetes? I am worried about his future and want to understand more about how insulin and T1D research are progressing to prevent this disease. What should we be doing to keep him safe? Please guide.

Thanks.

Answer 1

Hi,

Welcome to icliniq.com.

I can understand your concern.

Your concerns about your younger brother’s risk of developing type 1 diabetes (T1D) are understandable, especially with a family history of the condition. The good news is that there are advancements in immunotherapy and ongoing research aims at preventing or delaying the onset of T1D in high-risk individuals. Recent research focuses on immunotherapies that aim to preserve the function of beta cells (the cells in the pancreas that produce insulin) by targeting the autoimmune attack that causes T1D. One significant advancement is Teplizumab, an immunotherapy that has shown promise in delaying the onset of T1D in individuals who are at high risk. This medication works by modulating the immune system to reduce the attack on beta cells, thereby delaying the progression of the disease. It has been approved for use in the United States to delay the onset of T1D in individuals with specific autoantibodies and other risk markers. While it is not a cure, it can offer high-risk individuals more time before requiring insulin treatment.

To determine if your brother is at risk, screening for T1D autoantibodies is an important first step. There are specific blood tests that can identify markers indicating an increased likelihood of developing T1D. If these markers are present, he may be eligible to participate in clinical trials for preventive therapies like Teplizumab or other emerging treatments.

While T1D is not preventable in the traditional sense, there are things he can do to maintain his overall health. Following a balanced diet, promoting regular physical activity, and ensuring regular check-ups with his healthcare provider will help support his general well-being. Additionally, early detection of autoimmune activity is crucial for taking advantage of emerging interventions.

T1D research is progressing rapidly, and besides immunotherapy, other areas of study include beta cell regeneration and gene therapy, which aim to restore insulin production or prevent immune system attacks altogether.

Advances in insulin delivery systems, such as artificial pancreas devices, and closed-loop systems are also providing more effective glucose control for those who develop T1D.

In conclusion, getting your brother tested for T1D risk markers and staying informed about the latest developments in T1D research are great steps. New therapies are emerging that hold promise in delaying or even preventing the onset of T1D in high-risk individuals.

I hope this information will help you. Do get back in case of any further queries.

Thanks.